Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IRAK-1-4 Inhibitor I 是一种IRAK1/4双重抑制剂,其IC50分别为 0.2 μM 和 0.3 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 297 | 现货 | ||
2 mg | ¥ 433 | 现货 | ||
5 mg | ¥ 685 | 现货 | ||
10 mg | ¥ 938 | 现货 | ||
25 mg | ¥ 1,860 | 现货 | ||
50 mg | ¥ 3,150 | 现货 | ||
100 mg | ¥ 4,480 | 现货 | ||
500 mg | ¥ 9,330 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 693 | 现货 |
产品描述 | IRAK-1-4 Inhibitor I is a dual inhibitor of IRAK4 and IRAK1. |
靶点活性 | IRAK1:0.2 μM, IRAK4:0.3 μM |
体外活性 | IRAK-1-4 Inhibitor I has IC50 greater than the highest concentration tested (10 μM) against a panel of 27 other kinases, including the most closely homologous (outside of the IRAK family) Lck and pp60SRC. Additionally, IRAK-1-4 Inhibitor I does not show any signs of cytotoxicity in a 72 h proliferation assay in HeLa cells (ED50>30 μM). Significant inhibition of IRAK-1 is observed with IRAK-1-4 Inhibitor I (IRAK-1 IC50=0.3 μM)[1]. IRAK-1/4 inhibitor eliminates the LPS-induced increases in Bcl10, NF-κB, and IL-8. IRAK-1/4 mediates LPS-induced IL-8 activation and functions upstream of Bcl10. The LPS-induced increase in Bcl10 declines by 73% (from 5.18±0.22 to 2.36±0.08 ng/mL), and the IL-8 response decline by 60% (from 2.64±0.31 to 1.14±0.08 ng/mL)[2]. |
激酶实验 | Kinase Assays: Cell-free kinase assays are done in quadruplicate with 1 μM ATP to determine the IC50 values of AV-951 against a variety of recombinant receptor and nonreceptor tyrosine kinases including VEGFR1, VEGFR2, VEGFR3, c-Kit, PDGFRβ, Flt-3 and FGFR1. |
细胞实验 | IRAK-1-4 Inhibitor I is dissolved in DMSO and stored, and then diluted with appropriate media before use[2]. NCM460 cells, grown in 24-well plates, are incubated with 50 μM IRAK-1/4 inhibitor for 2 h. After 2 h, the media are changed, and new media with or without LPS (10 ng/mL) added. Treatment is terminated at 6 h, and spent media and cells are collected for IL-8 and other assays[2]. |
别名 | IRAK-1/4 Inhibitor I, IRAK-1/4 Inhibitor |
分子量 | 395.41 |
分子式 | C20H21N5O4 |
CAS No. | 509093-47-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 7.9 mg/mL(20 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.529 mL | 12.6451 mL | 25.2902 mL | 63.2255 mL |
5 mM | 0.5058 mL | 2.529 mL | 5.058 mL | 12.6451 mL | |
10 mM | 0.2529 mL | 1.2645 mL | 2.529 mL | 6.3226 mL | |
20 mM | 0.1265 mL | 0.6323 mL | 1.2645 mL | 3.1613 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
IRAK-1-4 Inhibitor I 509093-47-4 Immunology/Inflammation NF-Κb IRAK IRAK-1/4 Inhibitor I inhibit Interleukin-1 receptor associated kinase IRAK 1 4 Inhibitor I IRAK-1/4 Inhibitor IRAK14 Inhibitor I IL-1R associated kinase Inhibitor inhibitor